Corticosteroids for treatment of rheumatoid arthritis
Tanaka, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 1): 468-471
2005
ISSN/ISBN: 0047-1852 PMID: 15799401 Document Number: 590848
Document emailed within 1 workday
Related Documents
Kalbak, K. 1970: Incidence of arteriosclerosis in patients with rheumatoid arthritis (polyarthritis chronica) under long-term treatment with corticosteroids Ugeskrift for Laeger 132(45): 2115-2123Suhler, A.; Duplay, H.; Commandre, F.; Grimaud, D. 1973: Healthy pregnancy 24 years after ureterosigmoidostomy for bladder exstrophy, in spite of a prolonged treatment with chloraminophen and corticosteroids for chronic rheumatoid arthritis Journal d'Urologie et de Nephrologie 79(7): 599-604
Byron, M. 1996: The role of corticosteroids in rheumatoid arthritis British Journal of Hospital Medicine 55(5): 235-236
Amano, K. 2002: Systemic corticosteroids in rheumatoid arthritis: to use or not to use? Nihon Rinsho. Japanese Journal of Clinical Medicine 60(12): 2364-2369
Luftschein, S.; Bienenstock, H.; Varady, J.C.; Stitt, F.W. 1979: Increasing dose of naproxen in rheumatoid arthritis: use with and without corticosteroids Journal of Rheumatology 6(4): 397-404
Lems, W.F.; Jahangier, Z.N.; Jacobs, J.W.; Bijlsma, J.W. 1995: Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids Clinical and Experimental Rheumatology 13(3): 293-297
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Hutchinson, D.; Lynch, M. 2001: Sigmoid diverticular abscess perforation in 2 patients with rheumatoid arthritis treated with high dose corticosteroids. a cautionary tale Journal of Rheumatology 28(8): 1935-1936
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Lafforgue, P.; Monjanel-Mouterde, S.; Durand, A.; Catalin, J.; Acquaviva, P.C. 1993: Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? a pharmacokinetic study in 33 patients Journal of Rheumatology 20(2): 263-267
Macovei, L.; Ancuţa, C.; Pomîrleanu, C.; Chirieac, R. 2012: Identification of bone mass and bone turnover in patients with rheumatoid arthritis treated with corticosteroids in order to elaborate an optimal therapeutic approach Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(2): 470-476
Revaz, S.; Dudler, J. 2008: Diagnosis and treatment of rheumatoid vasculitis and other systemic complications of rheumatoid arthritis Revue Medicale Suisse 4(149): 712; 714 716-717
Langdon, C.G.; Moran, D.G.; Jamieson, V.; Spence, S.; Hill, S.A. 1990: A multicentre study of tenoxicam for the treatment of osteo-arthritis and rheumatoid arthritis in general practice Journal of International Medical Research 18(6): 489-496
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444